🇺🇸 FDA
Pipeline program

OKN4395

OKN-4395-121

Phase 1 small_molecule active

Quick answer

OKN4395 for Solid Tumours is a Phase 1 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Solid Tumours
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials